Flores, Maximo P.
HRN: 24-38-71 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/13/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
01/13/2024
01/20/2024
IV
600mg
Q8
Lacerated Wound
Checking Final Appropriateness
01/13/2024
CEFTRIAXONE 1G (VIAL)
01/13/2024
01/20/2024
IV
600mg
Q8
Lacerated Wound
Checking Final Appropriateness